Tenascin C Enhances the Development of Papillary Thyroid Carcinoma and has Diagnostic Significance in Papillary Thyroid Microcarcinoma
The Tohoku Journal of Experimental Medicine · 2025
DOI: 10.1620/tjem.2025.j043 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Tohoku Journal of Experimental Medicine, 2025. Verfasst von Qiwei Du und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thyroid and Breast Surgery, The First People's Hospital of Xiaoshan. Hauptthemen laut MEDLINE: Tenascin, Thyroid Neoplasms, Thyroid Cancer, Papillary, Carcinoma, Papillary. Die Arbeit nennt 40 Literaturangaben.
Abstract (Originalsprache)
Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer, a subtype of which is papillary thyroid microcarcinoma (PTMC). Tenascin C (TNC) is associated with the proliferation and metastasis of medullary thyroid cancer cells. Accordingly, this work was attempted to explore the role of TNC in quantitative real-time PCR (qRT-PCR). The pathological data of PTMC patients were recorded and analyzed. A transplant tumor mouse model was established using TPC-1 cells. The tumor volume and weight were documented, and the cells in the tumor tissues were isolated and cultured. The expressions of E-cadherin, Vimentin, and TNC in the tumor tissues, TPC-1 cells, and tumor cells were determined using qRT-PCR, Western blot, and immunohistochemistry. The viability, invasion, and migration of thyroid cells, PTC cells, and mouse tumor cells were further examined. TNC was upregulated in the serum of PTMC patients and PTC cells. PTMC patients with a higher level (≥ median) of TNC had more obvious lymph node metastasis and more severe tumor node metastasis (TNM) stage. TNC overexpression increased the viability, invasion, migration and Vimentin expression, while decreasing E-cadherin level in thyroid cells and PTC cells. TNC silencing reduced the tumor volume and weight, upregulated E-cadherin level in tumors, and also inhibited the viability, invasion, and migration of tumor cells. This work found that TNC enhances the development of PTC and serves as a promising diagnostic biomarker in PTMC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thyroid and Breast Surgery, The First People's Hospital of Xiaoshan.
- Department of Endocrine, The First People's Hospital of Xiaoshan.
Zitieren
APA
Du, Q., Zhang, M., Huang, Y., Wang, Z., Liu, N., & Li, R. (2025). Tenascin C Enhances the Development of Papillary Thyroid Carcinoma and has Diagnostic Significance in Papillary Thyroid Microcarcinoma. The Tohoku Journal of Experimental Medicine. https://doi.org/10.1620/tjem.2025.j043
Vancouver
Du Q, Zhang M, Huang Y, Wang Z, Liu N, Li R. Tenascin C Enhances the Development of Papillary Thyroid Carcinoma and has Diagnostic Significance in Papillary Thyroid Microcarcinoma. The Tohoku Journal of Experimental Medicine. 2025. doi:10.1620/tjem.2025.j043
BibTeX
@article{Du2025,
author = {Du, Qiwei and Zhang, Minghe and Huang, Yuqing and Wang, Ziqiang and Liu, Nian and Li, Rongguo},
title = {Tenascin C Enhances the Development of Papillary Thyroid Carcinoma and has Diagnostic Significance in Papillary Thyroid Microcarcinoma},
journal = {The Tohoku Journal of Experimental Medicine},
year = {2025},
doi = {10.1620/tjem.2025.j043}
}
EUVIMED